Risankizumab (anti-IL-23), 1mg*5

Risankizumab (anti-IL-23), 1mg*5

Alirocumab (anti-PCSK9), 1mg

Alirocumab (anti-PCSK9), 1mg

Risankizumab (anti-IL-23), 1mg*25

19.336,31 RON
SKU
SKM_A2046_1mg*25

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.